InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: None

Friday, 08/04/2017 12:55:50 PM

Friday, August 04, 2017 12:55:50 PM

Post# of 18220
It seems most interesting that no one seems to be asking for an accounting of the 75.9 % reduction in IMUN's equity interest in Cytocom, Inc. by purportedly "subsequent issuances of Cytocom, Inc . common stock to shareholders in settlement for notes payable."( As of March 31, 2017). What were the amounts and the conditions of settlement?